Deferiprone versus desferrioxamine in thalassaemia, and T2 validation and utility

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 361; no. 9352; p. 183
Main Authors Brittenham, GM, Nathan, DG, Olivieri, NF, Pippard, MJ, Weatherall, DJ
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 11.01.2003
Elsevier Limited
Subjects
beta-Thalassemia - drug therapy
beta-Thalassemia - mortality
Cardiomyopathies - mortality
Deferiprone
Deferoxamine - therapeutic use
Humans
Iron Chelating Agents - therapeutic use
Pyridones - therapeutic use
Reproducibility of Results
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(03)12223-4